Current research is focused on understanding the molecular mechanisms by which BET inhibitors exert their effects, optimizing drug formulations for pediatric use, and conducting clinical trials to establish efficacy and safety. Studies are also investigating combination therapies, where BET inhibitors are used alongside other treatments to enhance therapeutic outcomes.
